Cargando…

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI

Challenges remain for clinicians over balancing the efficacy of active antithrombotic therapy and simultaneous bleeding reduction in patients. The clinical data of 347 patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) were retrospectively analyzed. On th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yong-zhe, Zhao, Zi-wen, Li, Shu-mei, Chen, Liang-long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387390/ https://www.ncbi.nlm.nih.gov/pubmed/34433885 http://dx.doi.org/10.1038/s41598-021-96606-y

Ejemplares similares

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
por: Samaniego, Edgar A, et al.
Publicado: (2019)

Efficacy and safety of tirofiban bridge as an alternative to suspension of dual antiplatelet therapy in patients undergoing surgery: a systematic review
por: Riscado, Lorrane Vieira Siqueira, et al.
Publicado: (2021)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012)

Safety and Efficacy of Tirofiban in Severe Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
por: Cai, Lingxin, et al.
Publicado: (2022)

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)
por: Jiao, Yan, et al.
Publicado: (2022)

Tirofiban shows better platelet inhibition in diabetic patients during PCI procedures
Publicado: (2010)

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial
por: Shi, Xiujin, et al.
Publicado: (2021)

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke
por: Lee, John-Ih, et al.
Publicado: (2017)

Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke Etiology
por: Sun, Chao, et al.
Publicado: (2019)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Sex-related differences in clinical outcomes and predictive factors in the very elderly patients with ACS undergoing PCI
por: Wang, Jia-li, et al.
Publicado: (2022)

Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer?
por: Faxon, David P.
Publicado: (2020)

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
por: Christ, Günter, et al.
Publicado: (2014)

Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke
por: Han, Bin, et al.
Publicado: (2022)

Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention
por: Li, Lan, et al.
Publicado: (2017)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a ‘target trial’
por: Pufulete, Maria, et al.
Publicado: (2022)

Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke
por: Tao, Chunrong, et al.
Publicado: (2021)

Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI
por: Stimpfle, Fabian, et al.
Publicado: (2018)

Ultra-low CONtraSt PCI vs conVEntional PCI in patients of ACS with increased risk of CI-AKI (CONSaVE-AKI)()()
por: Shrivastava, Abhinav, et al.
Publicado: (2022)

Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI)
por: Gao, Lu, et al.
Publicado: (2016)

Safety and Efficacy of Tirofiban Combined with Statins in the Perioperative Period of Intracranial Aneurysms: Systematic Review and Meta-Analysis
por: Hao, Ming, et al.
Publicado: (2022)

Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy
por: Huo, Xiaochuan, et al.
Publicado: (2021)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Zeng, Qian, et al.
Publicado: (2020)

Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis
por: Sun, Lili, et al.
Publicado: (2020)

Safety and efficacy of prophylactic tirofiban infusion for acute intracranial intraprocedural stent thrombosis
por: Sun, Lili, et al.
Publicado: (2021)

Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction
por: Hu, Yinqin, et al.
Publicado: (2022)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

Retracted: Safety and Efficacy of Tirofiban Combined with Statins in the Perioperative Period of Intracranial Aneurysms: Systematic Review and Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Safety and efficacy of short-term dual antiplatelet therapy combined with intensive rosuvastatin in acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis
por: Mankerious, Nader, et al.
Publicado: (2023)

Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS
por: Wang, Jia-li, et al.
Publicado: (2021)

Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis
por: Huo, Xiaochuan, et al.
Publicado: (2020)

Efficacy of CPET Combined with Systematic Education of Cardiac Rehabilitation After PCI: A Real-World Evaluation in ACS Patients
por: Zhang, Quan-Yu, et al.
Publicado: (2021)

Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction
por: Zhang, Yuqing, et al.
Publicado: (2018)

Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis
por: Xu, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_00qc2ekqh6nn6sjdrvaepbs71f